Bearish flow noted in Teva with 6,226 puts trading, or 6x expected. Most active are Mar-24 10 puts and Jan-25 17 puts, with total volume in those strikes near 5,800 contracts. The Put/Call Ratio is 1.76, while ATM IV is up over 7 points on the day. Earnings are expected on January 31st.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TEVA:
- Piper still constructive on Corcept despite patent case ‘disappointing’ outcome
- Corcept Therapeutics says court finds patents not infringed
- Corcept selloff today ‘ideal buying opportunity,’ says Canaccord
- Corcept sinks after judge rules for Teva in Korlym patent case
- Corcept (NASDAQ:CORT) Faces Setback in Patent Case; Shares Decline